Pharmaceutical company Insmed is taking Wall Street by surprise today, falling to $66.29 and marking a -7.0% change compared ...

Boston Scientific expects the acquisition to have a positive impact on its future earnings. Specifically, the company ...

Thermo Fisher Scientific stock is trading -21.47% below its average target price of $653.35 after dropping -3.7% during today ...

Cytokinetics sank -8.2% this morning, compared to the S&P 500's day change of -1.0%. Today's losers may turn out to be ...

Gladstone Commercial Corporation is a real estate investment trust ("REIT") focused on acquiring, owning, and operating net ...

The cash flow from operating activities also experienced a decrease, with cash generated from operating activities declining ...

AT&T shares rose 1.9% this morning to a price of $22.68. The stock is still trading within range of its average target price ...

The notes will be senior, unsecured obligations of Upstart and will bear interest payable semi-annually in arrears. They will ...

Following Mr. Brubaker’s departure, Michael LiCalsi, the company’s General Counsel and Secretary, will assume certain ...

PureCycle Technologies, Inc. has recently released its 10-Q report, providing a comprehensive overview of the company's ...

David Eslick, Chairman and CEO of Marsh McLennan Agency, highlighted the potential for enhancing client-centric capabilities ...

CoStar's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 3.5%.